Literature DB >> 7386235

The natural history of stroke in diabetic patients.

K Asplund, E Hägg, C Helmers, F Lithner, T Strand, P O Wester.   

Abstract

A five-year follow-up of 53 diabetic patients admitted for their first stroke in 1972--73 has been performed. They were compared with two groups of 53 non-diabetic patients each with cerebrovascular disease (CVD), one randomly selected and one matched with the diabetics for age, sex and diagnosis of CVD at discharge. All patients could be traced at follow-up. The mean age at the time of first stroke was 66.5 years in male and 73.2 years in female diabetics. Manifest diabetes was diagnosed in 19% during hospitalization for stroke; of the remainder, 74% had had diabetes since less than ten years. In 85% of the diabetics there were no signs of severe angiopathy affecting eyes, kidneys or lower extremities. The majority of diabetic as well as non-diabetic CVD patients had a history of hypertension and/or heart disease. Few were overweight. Case fatality rate was significantly higher in diabetics than in non-diabetics throughout the follow-up (p less than 0.01 for diabetics vs. matched non-diabetics, p less than 0.001 for diabetics vs. randomly selected non-diabetics). The presence of heart disorder predicted mortality in the diabetic subjects. Surprisingly, hypertension diagnosed before stroke involved a more favourable long-term prognosis in all three groups (p less than 0.05). The major causes of death in diabetic CVD patients were cardiac disorders (50%) and stroke (47%). Previous investigations have identified diabetes as a risk factor for stroke. This study shows that diabetes also adversely affects the short-term as well as the long-term outcome in stroke.

Entities:  

Mesh:

Year:  1980        PMID: 7386235     DOI: 10.1111/j.0954-6820.1980.tb09749.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  21 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Stroke topography and outcome in relation to hyperglycaemia and diabetes.

Authors:  L Kiers; S M Davis; R Larkins; J Hopper; B Tress; S C Rossiter; J Carlin; S Ratnaike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

3.  Diabetes mellitus and early mortality from stroke.

Authors:  S M Oppenheimer; B I Hoffbrand; G A Oswald; J S Yudkin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

4.  The risk of venous thromboembolism is markedly elevated in patients with diabetes.

Authors:  V Petrauskiene; M Falk; I Waernbaum; M Norberg; J W Eriksson
Journal:  Diabetologia       Date:  2005-03-19       Impact factor: 10.122

Review 5.  Stroke prevention in diabetic and other high cardiovascular risk patients.

Authors:  Fadi El-Atat; Tanja Rundek; James R Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

6.  Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia.

Authors:  K Tanaka; N Ogawa; K Mizukawa; M Asanuma; Y Kondo; S Nishibayashi; A Mori
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

7.  The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke.

Authors:  N H Cox; J W Lorains
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

8.  Prognosis after stroke in diabetic patients. A controlled prospective study.

Authors:  T Olsson; M Viitanen; K Asplund; S Eriksson; E Hägg
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

9.  Venous thrombosis in diabetes mellitus.

Authors:  E W Jones; J R Mitchell
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

10.  Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients?

Authors:  D Toni; M L Sacchetti; C Argentino; M Gentile; C Cavalletti; M Frontoni; C Fieschi
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.